# Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes Mellitus

> **NCT01451398** · PHASE3 · COMPLETED · sponsor: **Mannkind Corporation** · enrollment: 353 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Technosphere® Insulin
- **DRUG:** Technosphere Powder

## Key facts

- **NCT ID:** NCT01451398
- **Lead sponsor:** Mannkind Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2013-06
- **Final completion:** 2013-07
- **Target enrollment:** 353 (ACTUAL)
- **Last updated:** 2014-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01451398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01451398, "Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01451398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*